Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: engaged (185), occupied (51), unavailable (47)

Papers Trust Board 6 June 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 06/06/2024 9:00 - 13:00 Conference Room, Heartbeat/Microsoft Teams J
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-6-June-2024.pdf

Teenage and young adult cancer care: maintenance chemotherapy for acute lymphoblastic leukaemia - patient information

Description: The last phase of ALL treatment is maintenance therapy. It helps to keep the leukaemia in remission. This factsheet tells you
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Teenage-and-young-adult-cancer-care-maintenance-chemotherapy-for-acute-lymphoblastic-leukaemia-2107-PIL.pdf

Annual report 15-16

Description: University Hospital Southampton NHS Foundation Trust Annual report and accounts 2015/16 incorporating the qualit
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-15-16.pdf

UHS AR 21-22 Quality Account

Description: QUALITY ACCOUNT 2021/22 Part 1: QStaUteAmeLnItToYn qAuaClitCy fOroUm NtheTchief executive 2021/22 1.1 Chief executive’s statement and welcome
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-21-22-Quality-Account.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Upadacitinib for the treatment of Crohn's disease and ulcerative colitis - patient information

Description: This factsheet explains what upadacitinib is, how people with Crohn's disease or ulcerative colitis should take it and the possible side
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Upadacitinib-for-the-treatment-of-Crohns-disease-and-ulcerative-colitis-3927-PIL.pdf

Papers Trust Board 27 May 2021

Description: Date Time Location Chair Agenda Trust Board – Open Session 27/05/2021 9:00 - 13:00 Microsoft Teams Peter Hollins 1 Chair’s Welcome, Apologies and Decla
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/TB-papers/Papers-Trust-Board-27-May-2021.pdf

Your child's medication: Iron supplement for restless legs syndrome - patient information

Description: This factsheet explains how your child should take iron supplements as part of their treatment programme for restless legs syndrome.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-medication-Iron-supplement-for-restless-legs-syndrome-3552-PIL.pdf

Metformin - patient information

Description: This factsheet explains what metformin is, and what the potential benefits and risks of taking it are.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Metformin-3180-PIL.pdf

Nintedanib - patient information

Description: This factsheet explains what Nintedanib is, why you have been prescribed it, how to take it and the potential side effects
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Nintedanib-3212-PIL.pdf

41 to 50 of 1000

Previous … 3 4 5 6 7 … Next